Should patients be allowed to opt out of routine genetic testing of colorectal tumors?

press release

TORONTO, Oct. 6, 2016--Health-care providers support routine testing of colorectal tumours to identify more individuals who have the most common genetic condition responsible for such cancers, a new study suggests.
And few felt patients should have the right to opt out of this test that would determine whether they have Lynch Syndrome, according to the study by Dr. Yvonne Bombard, a genomics and health services researcher in the Li Ka Shing Knowledge Institute of St. Michael's Hospital.
The study was published online today in the journal Genetics in Medicine.....

 Dr. Bombard interviewed surgeons, genetic counselors, oncologists, primary care physicians and gastroenterologists for their views and experiences on tumor testing, notification of results, counseling patients with Lynch Syndrome and their families, and their vision for the design and implementation of routine testing.

abstract: Universal tumor screening for Lynch syndrome: health-care providers’ perspectives